Mizuho initiates CNTY at Outperform
Mizuho starts coverage of Century Therapeutics with Outperform rating, citing potential growth prospects
Mizuho starts coverage of Century Therapeutics with Outperform rating, citing potential growth prospects
Mizuho starts coverage of Century Therapeutics with Outperform rating, citing potential growth prospects
Mizuho starts coverage of Century Therapeutics with Outperform rating, citing potential growth prospects